ASTRANA HEALTH INC (ASTH) Forecast, Price Target & Analyst Ratings

NASDAQ:ASTHUS03763A2078

Current stock price

24.8 USD
+0.2 (+0.81%)
At close:
24.8 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ASTRANA HEALTH INC (ASTH).

Forecast Snapshot

Consensus Price Target

Price Target
$36.38
+ 46.69% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$0.28
Revenue Estimate
952.64M

ChartMill Buy Consensus

Rating
84.71%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$36.38
Upside
+ 46.69%
From current price of $24.80 to mean target of $36.38, Based on 17 analyst forecasts
Low
$26.26
Median
$35.70
High
$52.50

Price Target Revisions

1 Month
-2.13%
3 Months
-11.39%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for ASTH. The average price target is 36.38 USD. This implies a price increase of 46.69% is expected in the next year compared to the current price of 24.8.
The average price target has been revised downward by 11.39% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

ASTH Current Analyst RatingASTH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ASTH Historical Analyst RatingsASTH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
84.71%
ASTH was analyzed by 17 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ASTH.
In the previous month the buy percentage consensus was at a similar level.
ASTH was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-13Truist SecuritiesMaintains Buy -> Buy
2026-02-02BTIGMaintains Buy -> Buy
2025-12-12NeedhamInitiate Buy
2025-11-25JefferiesMaintains Buy -> Buy
2025-11-24BarclaysMaintains Equal-Weight -> Equal-Weight
2025-11-10TD CowenMaintains Buy -> Buy
2025-11-07BTIGMaintains Buy -> Buy
2025-04-01BarclaysInitiate Equal-Weight
2025-03-18Truist SecuritiesMaintains Buy -> Buy
2025-03-04B of A SecuritiesMaintains Buy -> Buy
2025-03-03BairdMaintains Outperform -> Outperform
2025-02-20StifelMaintains Buy -> Buy
2025-01-13Truist SecuritiesMaintains Buy -> Buy
2024-11-13BairdMaintains Outperform -> Outperform
2024-10-14TD CowenInitiate Buy
2024-10-11KeybancInitiate Sector Weight
2024-10-03BTIGMaintains Buy -> Buy
2024-08-15BairdMaintains Outperform -> Outperform
2024-08-09Truist SecuritiesMaintains Buy -> Buy
2024-08-01StifelMaintains Buy -> Buy
2024-07-11Truist SecuritiesUpgrade Hold -> Buy
2024-06-27StifelMaintains Buy -> Buy
2024-05-30BairdInitiate Outperform
2024-05-08StifelMaintains Buy -> Buy
2024-03-01Truist SecuritiesMaintains Hold -> Hold

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$0.28
Revenue Estimate
952.64M
Revenue Q2Q
53.56%
EPS Q2Q
100.36%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.26%
EPS (1 Month)
0.00%
EPS (3 Months)
-30.36%

Next Earnings Summary

ASTH is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 0.28 USD and the consensus revenue estimate is 952.64M USD.
The next earnings revenue estimate has been revised upward by 0.26% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ASTH revenue by date.ASTH revenue by date.
1.144B
47.84%
1.387B
21.19%
2.035B
46.72%
3.224B
58.46%
4.037B
25.22%
4.472B
10.78%
4.316B
-3.49%
4.693B
8.73%
5.097B
8.61%
5.53B
8.50%
EBITDA
YoY % growth
ASTH ebitda by date.ASTH ebitda by date.
121.808M
5.28%
102.361M
-15.97%
117.277M
14.57%
209.33M
78.49%
270.62M
29.28%
317.48M
17.32%
346.8M
9.24%
391.68M
12.94%
442.68M
13.02%
499.8M
12.90%
EBIT
YoY % growth
ASTH ebit by date.ASTH ebit by date.
104.265M
6.20%
84.613M
-18.85%
89.35M
5.60%
84.427M
-5.51%
163.32M
93.45%
223.61M
36.92%
146.88M
-34.31%
192.78M
31.25%
241.74M
25.40%
294.78M
21.94%
Operating Margin
ASTH operating margin by date.ASTH operating margin by date.
9.11%6.10%4.39%2.62%4.05%5.00%3.40%4.11%4.74%5.33%
EPS
YoY % growth
ASTH eps by date.ASTH eps by date.
1.06
-32.48%
1.32
24.53%
0.89
-32.58%
0.50
-48.31%
1.26
174.35%
1.91
51.46%
3.05
59.55%
3.55
16.39%
4.03
13.51%
4.55
12.91%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.28
100.36%
0.31
61.82%
0.33
3,232.03%
0.23
90.65%
0.38
34.55%
0.59
92.42%
0.66
98.98%
0.42
82.80%
Revenue
Q2Q % growth
952.64M
53.56%
989.97M
51.18%
1.037B
8.47%
1.012B
6.47%
1.076B
12.95%
1.114B
12.53%
1.199B
15.62%
1.149B
13.54%
EBITDA
Q2Q % growth
65.046M
137.12%
70.193M
105.89%
77.492M
23.28%
65.562M
23.12%
67.697M
4.08%
81.61M
16.27%
87.853M
13.37%
72.308M
10.29%
EBIT
Q2Q % growth
36.358M
76.64%
35.869M
76.35%
42.136M
25.74%
31.47M
31.31%
24.259M
-33.28%
30.932M
-13.76%
31.773M
-24.59%
33.16M
5.37%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ASTH Yearly Revenue VS EstimatesASTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
ASTH Yearly EPS VS EstimatesASTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
87.86%
EPS Next 5 Year
54.34%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
10.21%
Revenue Next 5 Year
9.59%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
45.21%
EBIT Next 5 Year
30.45%

ASTRANA HEALTH INC / ASTH Forecast FAQ

What do analysts expect the price target to be for ASTRANA HEALTH INC (ASTH)?

17 analysts have analysed ASTH and the average price target is 36.38 USD. This implies a price increase of 46.69% is expected in the next year compared to the current price of 24.8.

When does ASTRANA HEALTH INC (ASTH) report earnings?

ASTRANA HEALTH INC (ASTH) will report earnings on 2026-05-06.

What are the consensus estimates for ASTRANA HEALTH INC (ASTH) next earnings?

The consensus EPS estimate for the next earnings of ASTRANA HEALTH INC (ASTH) is 0.28 USD and the consensus revenue estimate is 952.64M USD.

Can you provide the analyst count for ASTRANA HEALTH INC stock?

The number of analysts covering ASTRANA HEALTH INC (ASTH) is 17.